Auditory Cinchonism in COVID Era.
作者信息
Saniasiaya Jeyasakthy, Kulasegarah Jeyanthi
机构信息
Department of Otorhinolaryngology, 173800Hospital Tuanku Ja'afar, Jalan Rasah, Seremban, Negeri Sembilan, Malaysia.
Department of Otorhinolaryngology, Faculty of Medicine, 65300University of Malaya, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia.
出版信息
Ear Nose Throat J. 2020 Nov;99(9):597-598. doi: 10.1177/0145561320947255. Epub 2020 Aug 3.
Abstract
摘要
相似文献
1
Auditory Cinchonism in COVID Era.
Ear Nose Throat J. 2020 Nov;99(9):597-598. doi: 10.1177/0145561320947255. Epub 2020 Aug 3.
2
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.
CMAJ. 2020 Apr 27;192(17):E450-E453. doi: 10.1503/cmaj.200528. Epub 2020 Apr 8.
3
Hydroxychloroquine-induced erythema multiforme in a patient with COVID-19.
Med Clin (Barc). 2020 Sep 11;155(5):231. doi: 10.1016/j.medcli.2020.05.004. Epub 2020 May 19.
4
Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
Clin Microbiol Infect. 2020 Sep;26(9):1276-1277. doi: 10.1016/j.cmi.2020.05.006. Epub 2020 May 16.
5
Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence.
Med Clin (Barc). 2020 Aug 14;155(3):134-135. doi: 10.1016/j.medcli.2020.05.006. Epub 2020 May 16.
6
Chloroquine and hydroxychloroquine in covid-19.
BMJ. 2020 Apr 8;369:m1432. doi: 10.1136/bmj.m1432.
7
Hydroxychloroquine in Covid-19: Does the end justify the means?
Curr Res Transl Med. 2020 Aug;68(3):81-82. doi: 10.1016/j.retram.2020.04.002. Epub 2020 Apr 18.
8
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Trials. 2020 Jun 10;21(1):513. doi: 10.1186/s13063-020-04409-9.
9
Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment.
Circulation. 2020 Jun 16;141(24):e906-e907. doi: 10.1161/CIRCULATIONAHA.120.047521. Epub 2020 Apr 8.
10
Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients.
Indian J Pharmacol. 2020 May-Jun;52(3):229-231. doi: 10.4103/ijp.IJP_595_20. Epub 2020 Aug 4.
引用本文的文献
1
Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies.
Arch Microbiol Immunol. 2023;7(2):36-61. Epub 2023 May 9.
2
Neuro-otological Symptoms: An Atypical Aspect of COVID-19 Disease.
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):3273-3282. doi: 10.1007/s12070-022-03088-z. Epub 2022 Apr 15.
3
New onset tinnitus in the absence of hearing changes following COVID-19 infection.
Am J Otolaryngol. 2022 Jan-Feb;43(1):103208. doi: 10.1016/j.amjoto.2021.103208. Epub 2021 Sep 10.
4
SARS-CoV-2 (COVID-19) and audio-vestibular disorders.
Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211027373. doi: 10.1177/20587384211027373.
5
Hearing Loss, Tinnitus, and Dizziness in COVID-19: A Systematic Review and Meta-Analysis.
Can J Neurol Sci. 2022 Mar;49(2):184-195. doi: 10.1017/cjn.2021.63. Epub 2021 Apr 12.
本文引用的文献
1
Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review.
Front Public Health. 2020 May 29;8:252. doi: 10.3389/fpubh.2020.00252. eCollection 2020.
2
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237.
3
A case report of hearing loss post use of hydroxychloroquine in a HIV-infected patient.
Daru. 2014 Jan 22;22(1):20. doi: 10.1186/2008-2231-22-20.
4
Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: a reasoned and updated guide.
Eur Rev Med Pharmacol Sci. 2011 Jun;15(6):601-36.
5
Chloroquine ototoxicity.
Clin Rheumatol. 2007 Nov;26(11):1809-10. doi: 10.1007/s10067-007-0662-6. Epub 2007 Jun 27.
Zotero 插件